Enhanced mosquito vectorial capacity underlies the Cape Verde Zika epidemic.


Journal

PLoS biology
ISSN: 1545-7885
Titre abrégé: PLoS Biol
Pays: United States
ID NLM: 101183755

Informations de publication

Date de publication:
10 2022
Historique:
received: 13 07 2022
accepted: 03 10 2022
entrez: 26 10 2022
pubmed: 27 10 2022
medline: 29 10 2022
Statut: epublish

Résumé

The explosive emergence of Zika virus (ZIKV) across the Pacific and Americas since 2007 was associated with hundreds of thousands of human cases and severe outcomes, including congenital microcephaly caused by ZIKV infection during pregnancy. Although ZIKV was first isolated in Uganda, Africa has so far been exempt from large-scale ZIKV epidemics, despite widespread susceptibility among African human populations. A possible explanation for this pattern is natural variation among populations of the primary vector of ZIKV, the mosquito Aedes aegypti. Globally invasive populations of Ae. aegypti outside of Africa are considered effective ZIKV vectors because they are human specialists with high intrinsic ZIKV susceptibility, whereas African populations of Ae. aegypti across the species' native range are predominantly generalists with low intrinsic ZIKV susceptibility, making them less likely to spread viruses in the human population. We test this idea by studying a notable exception to the patterns observed across most of Africa: Cape Verde experienced a large ZIKV outbreak in 2015 to 2016. We find that local Ae. aegypti in Cape Verde have substantial human-specialist ancestry, show a robust behavioral preference for human hosts, and exhibit increased susceptibility to ZIKV infection, consistent with a key role for variation among mosquito populations in ZIKV epidemiology. These findings suggest that similar human-specialist populations of Ae. aegypti in the nearby Sahel region of West Africa, which may be expanding in response to rapid urbanization, could serve as effective vectors for ZIKV in the future.

Identifiants

pubmed: 36288328
doi: 10.1371/journal.pbio.3001864
pii: PBIOLOGY-D-22-01519
pmc: PMC9604947
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3001864

Subventions

Organisme : NIDCD NIH HHS
ID : R00 DC012069
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Gen Virol. 2018 Sep;99(9):1248-1252
pubmed: 29975185
Lancet Infect Dis. 2019 Oct;19(10):1138-1147
pubmed: 31559967
Parasit Vectors. 2020 Sep 21;13(1):481
pubmed: 32958043
Emerg Infect Dis. 2020 Jun;26(6):1084-1090
pubmed: 32441631
Curr Biol. 2016 Jan 11;26(1):R41-6
pubmed: 26766234
Nature. 2014 Nov 13;515(7526):222-7
pubmed: 25391959
Arch Med Res. 2002 Jul-Aug;33(4):379-88
pubmed: 12234528
J Vector Ecol. 2010 Dec;35(2):307-12
pubmed: 21175936
Nat Commun. 2021 Feb 10;12(1):916
pubmed: 33568638
BMC Biol. 2017 Feb 28;15(1):16
pubmed: 28241828
PLoS Negl Trop Dis. 2014 Feb 06;8(2):e2681
pubmed: 24516683
Curr Biol. 2020 Sep 21;30(18):3570-3579.e6
pubmed: 32707056
Science. 2014 Oct 10;346(6206):234-7
pubmed: 25301627
Ecol Evol. 2018 Jul 13;8(16):7835-7848
pubmed: 30250667
Trans R Soc Trop Med Hyg. 1952 Sep;46(5):509-20
pubmed: 12995440
Emerg Infect Dis. 2020 May;26(5):945-952
pubmed: 32310065
Annu Rev Med. 2018 Jan 29;69:395-408
pubmed: 28846489
N Engl J Med. 2009 Jun 11;360(24):2536-43
pubmed: 19516034
Cell Host Microbe. 2019 Sep 11;26(3):309-313
pubmed: 31513769
Bull World Health Organ. 1972;47(5):680-3
pubmed: 4540689
PLoS Med. 2017 Jan 3;14(1):e1002203
pubmed: 28045901
Lancet Planet Health. 2020 Sep;4(9):e416-e423
pubmed: 32918887
Int J Environ Res Public Health. 2018 Jan 28;15(2):
pubmed: 29382107
N Engl J Med. 2019 Oct 10;381(15):1444-1457
pubmed: 31597021
Science. 2020 Nov 20;370(6519):991-996
pubmed: 33214283
Mol Ecol. 2016 Nov;25(21):5377-5395
pubmed: 27671732
Bioscience. 2018 Nov 1;68(11):854-860
pubmed: 30464351
Ecol Evol. 2021 Nov 09;11(22):16327-16343
pubmed: 34824830
Am J Trop Med Hyg. 2018 Sep;99(3):756-763
pubmed: 29988000
Evol Appl. 2019 Aug 03;12(9):1797-1811
pubmed: 31548858
Trans R Soc Trop Med Hyg. 2017 Nov 1;111(11):527-529
pubmed: 29394415
Annu Rev Entomol. 2020 Jan 7;65:191-208
pubmed: 31594415
PLoS Pathog. 2012;8(4):e1002588
pubmed: 22496640

Auteurs

Noah H Rose (NH)

Department of Ecology & Evolutionary Biology, Princeton University, Princeton, New Jersey, United States of America.
Princeton Neuroscience Institute, Princeton University, Princeton, New Jersey, United States of America.

Stéphanie Dabo (S)

Institut Pasteur, Université Paris Cité, CNRS UMR2000, Insect-Virus Interactions Unit, Paris, France.

Silvânia da Veiga Leal (S)

Laboratório de Entomologia Médica, Instituto Nacional de Saúde Pública, Praia, Cabo Verde.

Massamba Sylla (M)

Department of Livestock Sciences and Techniques, University Sine Saloum El Hadji Ibrahima NIASS, Kaffrine, Senegal.

Cheikh T Diagne (CT)

Institut Pasteur Dakar, Arbovirus and Viral Hemorrhagic Fevers Unit, Dakar, Senegal.

Oumar Faye (O)

Institut Pasteur Dakar, Arbovirus and Viral Hemorrhagic Fevers Unit, Dakar, Senegal.

Ousmane Faye (O)

Institut Pasteur Dakar, Arbovirus and Viral Hemorrhagic Fevers Unit, Dakar, Senegal.

Amadou A Sall (AA)

Institut Pasteur Dakar, Arbovirus and Viral Hemorrhagic Fevers Unit, Dakar, Senegal.

Carolyn S McBride (CS)

Department of Ecology & Evolutionary Biology, Princeton University, Princeton, New Jersey, United States of America.
Princeton Neuroscience Institute, Princeton University, Princeton, New Jersey, United States of America.

Louis Lambrechts (L)

Institut Pasteur, Université Paris Cité, CNRS UMR2000, Insect-Virus Interactions Unit, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH